Cargando…

Progress in eliminating HPV-associated disease

Detalles Bibliográficos
Autores principales:	Stern, Peter L., Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739488/ https://www.ncbi.nlm.nih.gov/pubmed/31425856 http://dx.doi.org/10.1016/j.pvr.2019.100180

Ejemplares similares

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
por: Canfell, Karen, et al.
Publicado: (2021)

Towards the global elimination of cervical cancer
por: Canfell, Karen
Publicado: (2019)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake
por: Smith, Megan A., et al.
Publicado: (2014)

Elimination of reserve cells for prevention of HPV-associated cervical cancer
por: Reich, Olaf, et al.
Publicado: (2023)

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

Opportunities to improve immune-based prevention of HPV-associated cancers
por: Stern, Peter L., et al.
Publicado: (2019)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression
por: Mukherjee, Sumit, et al.
Publicado: (2017)

A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
por: Velentzis, Louiza S, et al.
Publicado: (2023)

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
por: Smith, Megan A., et al.
Publicado: (2016)

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China
por: Wei, Lihui, et al.
Publicado: (2021)

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
por: Canfell, Karen, et al.
Publicado: (2019)

Population-based utility scores for HPV infection and oropharyngeal squamous cell carcinoma among Indigenous Australians
por: Ju, Xiangqun, et al.
Publicado: (2021)

Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
por: Stanley, M
Publicado: (2007)

Natural History of Oral HPV Infection among Indigenous South Australians
por: Ju, Xiangqun, et al.
Publicado: (2023)

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea
por: Nguyen, Diep Thi Ngoc, et al.
Publicado: (2022)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women
por: Ju, Xiangqun, et al.
Publicado: (2021)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

HPV vaccine: uptake and understanding among global Indigenous communities – a qualitative systematic review
por: Poirier, Brianna, et al.
Publicado: (2021)

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program
por: Pearson, Amber L, et al.
Publicado: (2014)

Elimination of Cancer Health Disparities through the Acceleration of HPV Vaccines and Vaccinations: A Simplified Version of the President’s Cancer Panel Report on HPV Vaccinations
por: McGhee, Eva, et al.
Publicado: (2017)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Modeling Progress Toward Elimination of Hepatitis B in Australia
por: McCulloch, Karen, et al.
Publicado: (2019)

Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand
por: Kang, Yoon-Jung, et al.
Publicado: (2015)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review
por: Sethi, Sneha, et al.
Publicado: (2021)

Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
por: Gupta, Sadhana M., et al.
Publicado: (2019)

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
por: Baussano, Iacopo, et al.
Publicado: (2017)

The role of integration in oncogenic progression of HPV-associated cancers
por: McBride, Alison A., et al.
Publicado: (2017)

Onchocerciasis Elimination: Progress and Challenges
por: Lakwo, Thomson, et al.
Publicado: (2020)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2h921b0lh1cpjlmabcckcl47dj